Increased Expression of Pregnancy Up-regulated Non-ubiquitous Calmodulin Kinase is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 May 2

PMID 23634203

Citations 15

Authors

Song Wu

Zhaojie Lv

Yong Wang

Liang Sun

Zhimao Jiang

Congjie Xu

Jun Zhao

Xiaojuan Sun

Xianxin Li

Lijun Hu

Aifa Tang

Yaoting Gui

Fangjian Zhou

Zhiming Cai

Rongfu Wang

Affiliations

Soon will be listed here.

Abstract

Purpose: The aims of this study were to evaluate the clinical significance and potential prognostic value of pregnancy up-regulated non-ubiquitous calmodulin kinase (PNCK) in clear cell renal cell carcinoma (ccRCC) patients.

Materials And Methods: The expression of PNCK mRNA was determined in 24 paired samples of ccRCCs and adjacent normal tissues using real-time RT-PCR. The expression of PNCK was determined in 248 samples of ccRCCs and 92 paired samples of adjacent normal tissues by immunohistochemical analysis. Statistical analysis was performed to define the relationship between PNCK expression and the clinical features of ccRCC.

Results: The mRNA level of PNCK was significantly higher in tumorous tissues than in the adjacent non-tumorous tissues (p<0.001). An immunohistochemical analysis of 92 paired tissue specimens showed that PNCK expression was higher in tumorous tissues than in the adjacent non-tumorous tissues (p<0.001). Moreover, there was a significant correlation between the PNCK expression and various clinicopathological parameters such as Fuhrman grade (p = 0.011), tumor size (p<0.001), T stage (p<0.001) and N stage (p = 0.015). Patients with higher PNCK expression had shorter overall survival time than those with lower PNCK expression (p<0.001). Multivariate analysis indicated that PNCK expression was an independent predictor for poor survival of ccRCC patients.

Conclusions: To our knowledge, this is the first study that determines the relationship between PNCK and prognosis in ccRCC. We found that increased PNCK expression is associated with poor prognosis in ccRCC. PNCK may represent a novel prognostic marker for ccRCC.

Citing Articles

Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors.

Ding Q, Weng Y, Li Y, Lin W, Lin X, Lin T J Immunother Cancer. 2024; 12(10).

PMID: 39395840 PMC: 11474745. DOI: 10.1136/jitc-2024-009893.

Genetic Risk Loci and Familial Associations in Migraine: A Genome-Wide Association Study in the Han Chinese Population of Taiwan.

Liu Y, Yeh P, Lin Y, Liang C, Tsai C, Lin G J Clin Neurol. 2024; 20(4):439-449.

PMID: 38951977 PMC: 11220351. DOI: 10.3988/jcn.2023.0331.

Regulation of ErbB Receptors by the Ca Sensor Protein Calmodulin in Cancer.

Villalobo A Biomedicines. 2023; 11(3).

PMID: 36979639 PMC: 10045772. DOI: 10.3390/biomedicines11030661.

Cellular and molecular effects of PNCK, a non-canonical kinase target in renal cell carcinoma.

Essegian D, Chavez V, Bustamante F, Schurer S, Merchan J iScience. 2022; 25(12):105621.

PMID: 36465101 PMC: 9713373. DOI: 10.1016/j.isci.2022.105621.

Upregulation of PNCK Promotes Metastasis and Angiogenesis via Activating NF-B/VEGF Pathway in Nasopharyngeal Carcinoma.

Chen X, Weng Y, Li Y, Fu W, Huang Z, Pan Y J Oncol. 2022; 2022:8541582.

PMID: 35535310 PMC: 9078829. DOI: 10.1155/2022/8541582.

References

Wei C, Wu S, Li X, Wang Y, Ren R, Lai Y . High expression of FER tyrosine kinase predicts poor prognosis in clear cell renal cell carcinoma. Oncol Lett. 2013; 5(2):473-478. PMC: 3573111. DOI: 10.3892/ol.2012.1032. View

Sorbellini M, Kattan M, Snyder M, Reuter V, Motzer R, Goetzl M . A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol. 2004; 173(1):48-51. DOI: 10.1097/01.ju.0000148261.19532.2c. View

Sabatino M, Kim-Schulze S, Panelli M, Stroncek D, Wang E, Taback B . Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy. J Clin Oncol. 2009; 27(16):2645-52. PMC: 2689845. DOI: 10.1200/JCO.2008.19.1106. View

Deb T, Zuo A, Wang Y, Barndt R, Cheema A, Sengupta S . Pnck induces ligand-independent EGFR degradation by probable perturbation of the Hsp90 chaperone complex. Am J Physiol Cell Physiol. 2011; 300(5):C1139-54. PMC: 3093937. DOI: 10.1152/ajpcell.00167.2010. View

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View

Gardner H, Rajan J, Ha S, Copeland N, Gilbert D, Jenkins N . Cloning, characterization, and chromosomal localization of Pnck, a Ca(2+)/calmodulin-dependent protein kinase. Genomics. 2000; 63(2):279-88. DOI: 10.1006/geno.1999.6091. View

Iliopoulos O . Molecular biology of renal cell cancer and the identification of therapeutic targets. J Clin Oncol. 2006; 24(35):5593-600. DOI: 10.1200/JCO.2006.08.8948. View

Ljungberg B, Cowan N, Hanbury D, Hora M, Kuczyk M, Merseburger A . EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol. 2010; 58(3):398-406. DOI: 10.1016/j.eururo.2010.06.032. View

Wood L . New therapeutic strategies for renal cell carcinoma. Urol Nurs. 2010; 30(1):40-53. DOI: 10.7257/1053-816x.2010.30.1.40. View

10.

Klatte T, Rao P, de Martino M, LaRochelle J, Shuch B, Zomorodian N . Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J Clin Oncol. 2009; 27(5):746-53. DOI: 10.1200/JCO.2007.15.8345. View

11.

Frank I, Blute M, Cheville J, Lohse C, Weaver A, Zincke H . An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol. 2002; 168(6):2395-400. DOI: 10.1016/S0022-5347(05)64153-5. View

12.

Deb T, Coticchia C, Barndt R, Zuo H, Dickson R, Johnson M . Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation. Am J Physiol Cell Physiol. 2008; 295(2):C365-77. PMC: 2518423. DOI: 10.1152/ajpcell.00449.2007. View

13.

Ueda T, Sakagami H, Abe K, Oishi I, Maruo A, Kondo H . Distribution and intracellular localization of a mouse homologue of Ca2+/calmodulin-dependent protein kinase Ibeta2 in the nervous system. J Neurochem. 1999; 73(5):2119-29. View

14.

Grignon D, Che M . Clear cell renal cell carcinoma. Clin Lab Med. 2005; 25(2):305-16. DOI: 10.1016/j.cll.2005.01.012. View

15.

Mulders P, Brouwers A, Hulsbergen-van der Kaa C, van Lin E, Osanto S, De Mulder P . [Guideline 'Renal cell carcinoma']. Ned Tijdschr Geneeskd. 2008; 152(7):376-80. View

16.

Cheng L, Zhang S, MacLennan G, Lopez-Beltran A, Montironi R . Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol. 2008; 40(1):10-29. DOI: 10.1016/j.humpath.2008.09.009. View

17.

Wu S, Sun X, Zhu W, Huang Y, Mou L, Liu M . Evidence for GAL3ST4 mutation as the potential cause of pectus excavatum. Cell Res. 2012; 22(12):1712-5. PMC: 3515755. DOI: 10.1038/cr.2012.149. View

18.

Jusuf A, Sakagami H, Kikkawa S, Kondo H, Minami Y, Terashima T . Distribution of Ca(2+)/calmodulin-dependent protein kinase I beta 2 in the central nervous system of the rat. Brain Res. 2001; 911(1):1-11. DOI: 10.1016/s0006-8993(01)02440-4. View

19.

Chow W, Dong L, Devesa S . Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010; 7(5):245-57. PMC: 3012455. DOI: 10.1038/nrurol.2010.46. View

20.

Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu M . Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell. 2004; 5(4):329-39. DOI: 10.1016/s1535-6108(04)00081-9. View